Sema / B12
Enhanced Glycemic Control
Semaglutide lowers hemoglobin A1c by up to 2 percentage points, improving long-term blood sugar management in type 2 diabetes
Cardiovascular Protection
Large clinical trials demonstrated up to a 26% reduction in major cardiovascular events (heart attack, stroke) in adults with overweight or obesity